TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
358,574
|
331,747
|
294,333 |
| Financial expenses |
61
|
6
|
534 |
| Earnings before taxes |
9,613
|
5,505
|
3,839 |
| EBITDA |
11,798
|
7,114
|
7,134 |
| Total assets |
141,667
|
137,560
|
114,721 |
| Current assets |
131,435
|
126,132
|
102,307 |
| Current liabilities |
96,325
|
86,340
|
64,105 |
| Equity capital |
15,184
|
24,040
|
28,684 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
34
|
31
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.7%
|
17.5%
|
25.0% |
| Turnover per employee |
10,546
|
10,702
|
10,901 |
| Profit as a percentage of turnover |
2.7%
|
1.7%
|
1.3% |
| Return on assets (ROA) |
6.8%
|
4.0%
|
3.8% |
| Current ratio |
136.4%
|
146.1%
|
159.6% |
| Return on equity (ROE) |
63.3%
|
22.9%
|
13.4% |
| Change turnover |
20,846
|
16,529
|
-15,969 |
| Change turnover % |
6%
|
5%
|
-5% |
| Chg. No. of employees |
3
|
4
|
0 |
| Chg. No. of employees % |
10%
|
15%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.